Matthew Blakiston

687 total citations
18 papers, 148 citations indexed

About

Matthew Blakiston is a scholar working on Epidemiology, Infectious Diseases and Clinical Biochemistry. According to data from OpenAlex, Matthew Blakiston has authored 18 papers receiving a total of 148 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Epidemiology, 7 papers in Infectious Diseases and 3 papers in Clinical Biochemistry. Recurrent topics in Matthew Blakiston's work include Respiratory viral infections research (3 papers), Tuberculosis Research and Epidemiology (3 papers) and Antibiotic Use and Resistance (3 papers). Matthew Blakiston is often cited by papers focused on Respiratory viral infections research (3 papers), Tuberculosis Research and Epidemiology (3 papers) and Antibiotic Use and Resistance (3 papers). Matthew Blakiston collaborates with scholars based in New Zealand, United Kingdom and Nigeria. Matthew Blakiston's co-authors include Susan C. Morpeth, Joshua T. Freeman, Susan Taylor, Conroy Wong, Sally Roberts, Lovett Lawson, Luís E. Cuevas, Olanrewaju Oladimeji, Nikhil Sapre and Joshua Obasanya and has published in prestigious journals such as PLoS ONE, Journal of Clinical Microbiology and PLoS neglected tropical diseases.

In The Last Decade

Matthew Blakiston

15 papers receiving 141 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matthew Blakiston New Zealand 7 68 43 32 22 20 18 148
Khaled Alshabani United States 9 69 1.0× 73 1.7× 28 0.9× 92 4.2× 33 1.6× 17 204
John Midturi United States 8 55 0.8× 61 1.4× 7 0.2× 33 1.5× 25 1.3× 16 136
Diane Ponscarme France 8 81 1.2× 78 1.8× 16 0.5× 13 0.6× 15 0.8× 11 192
Handan Alay Türkiye 8 75 1.1× 54 1.3× 10 0.3× 18 0.8× 27 1.4× 48 197
Costanza Di Chiara Italy 10 135 2.0× 35 0.8× 4 0.1× 16 0.7× 24 1.2× 33 246
Ashish Satav India 10 71 1.0× 69 1.6× 6 0.2× 15 0.7× 28 1.4× 22 191
Rajesh Karyakarte India 8 113 1.7× 62 1.4× 5 0.2× 17 0.8× 11 0.6× 33 207
Shengyu Huang China 8 92 1.4× 61 1.4× 36 1.1× 11 0.5× 10 0.5× 19 246
Alfredo J Mena Lora United States 6 32 0.5× 28 0.7× 9 0.3× 12 0.5× 10 0.5× 32 94
Kennedy Nyamande South Africa 8 94 1.4× 149 3.5× 13 0.4× 36 1.6× 23 1.1× 14 214

Countries citing papers authored by Matthew Blakiston

Since Specialization
Citations

This map shows the geographic impact of Matthew Blakiston's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew Blakiston with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew Blakiston more than expected).

Fields of papers citing papers by Matthew Blakiston

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew Blakiston. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew Blakiston. The network helps show where Matthew Blakiston may publish in the future.

Co-authorship network of co-authors of Matthew Blakiston

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew Blakiston. A scholar is included among the top collaborators of Matthew Blakiston based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew Blakiston. Matthew Blakiston is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
Blakiston, Matthew, et al.. (2025). Clinical alert: arrival of terbinafine resistant Trichophyton indotineae in New Zealand. New Zealand Medical Journal. 138(1610). 31–38. 1 indexed citations
2.
Blakiston, Matthew, et al.. (2024). Characterisation ofNeisseria gonorrhoeaestrain differences in patients with multisite infection. Sexually Transmitted Infections. 101(2). 88–93. 1 indexed citations
3.
5.
Roberts, Sally, Matthew Blakiston, Mark B. Schultz, et al.. (2022). Epidemiology of carbapenem resistant Acinetobacter baumannii in New Zealand. New Zealand Medical Journal. 135(1561). 76–82. 5 indexed citations
7.
8.
Muttaiyah, Sharmini, et al.. (2020). Age-related differences in SARS-CoV-2 testing in the Northern Region of New Zealand.. PubMed. 133(1519). 89–94. 1 indexed citations
9.
Blakiston, Matthew & Joshua T. Freeman. (2020). Population-level exposures associated with MRSA and ESBL-E. coli infection across district health boards in Aotearoa New Zealand: an ecological study.. PubMed. 133(1510). 62–69. 4 indexed citations
10.
Blakiston, Matthew, et al.. (2019). Household transmission of NDM-producing E. coli in New Zealand. PubMed. 130(1452). 63–65. 1 indexed citations
11.
Blakiston, Matthew, Helen Heffernan, Sally Roberts, & Joshua T. Freeman. (2019). The clear and present danger of carbapenemase-producing Enterobacteriaceae (CPE) in New Zealand: time for a national response plan. PubMed. 130(1454). 72–79. 5 indexed citations
12.
Freeman, Joshua T., Matthew Blakiston, & Deverick J. Anderson. (2018). Hospital-Onset MRSA Bacteremia Rates Are Significantly Correlated With Sociodemographic Factors: A Step Toward Risk Adjustment. Infection Control and Hospital Epidemiology. 39(4). 479–481. 7 indexed citations
13.
Blakiston, Matthew, et al.. (2018). Diagnostic Performance of Pleural Fluid Adenosine Deaminase for Tuberculous Pleural Effusion in a Low-Incidence Setting. Journal of Clinical Microbiology. 56(8). 24 indexed citations
14.
Lawson, Lovett, Matthew Blakiston, Joshua Obasanya, et al.. (2016). Are patients with pulmonary tuberculosis who are identified through active case finding in the community different than those identified in healthcare facilities?. New Microbes and New Infections. 15. 35–39. 6 indexed citations
15.
Hertog, Alice L. den, Matthew Blakiston, Sandra Menting, et al.. (2015). Cytokine Kinetics in the First Week of Tuberculosis Therapy as a Tool to Confirm a Clinical Diagnosis and Guide Therapy. PLoS ONE. 10(6). e0129552–e0129552. 13 indexed citations
16.
Lawson, Lovett, Olanrewaju Oladimeji, Matthew Blakiston, et al.. (2015). Testing Pooled Sputum with Xpert MTB/RIF for Diagnosis of Pulmonary Tuberculosis To Increase Affordability in Low-Income Countries. Journal of Clinical Microbiology. 53(8). 2502–2508. 28 indexed citations
17.
Sapre, Nikhil, et al.. (2008). In sight, in mind: Retailer compliance with legislation on limiting retail tobacco displays. Nicotine & Tobacco Research. 10(8). 1347–1354. 31 indexed citations
18.
Blakiston, Matthew, et al.. (2006). Cigarettes and Candy A Study of Retailer Compliance with the Point of Sale Tobacco Display Regulations in the 2003 Smoke-free Environments Amendment Act. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026